US Anti-Snoring Devices and Snoring Surgery Market Size, Share, Growth, Trends, and Industry Analysis: By Device, Tongue-Retaining Devices, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, Expiratory Positive Airway Pressure), By Surgical Procedure, By Distribution Channel and Country

US Anti-Snoring Devices and Snoring Surgery Market Size, Share, Growth, Trends, and Industry Analysis: By Device (Oral Devices Mandibular Advancement Devices (MADS), Tongue-Retaining Devices (TRDS), Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, Expiratory Positive Airway Pressure), By Surgical Procedure (Uvulopalatopharyngoplasty, Pillar Procedure, Laser-Assisted Uvulopalatoplasty, Radiofrequency Ablation, Sclerotherapy, Septoplasty, Palatal Stiffening Procedures, Injection Snoreplasty/Sclerotherapy), By Distribution Channel (Hospitals and Clinics) and Country

The US anti-snoring devices and snoring surgery market size was valued at US$ 538.6 million in 2023 and is projected to reach US$ 917.1 million by 2030, growing at a CAGR of 7.9% from 2024 to 2030. The U.S. Anti-Snoring Devices and Snoring Surgery market is being fuelled by awareness about sleep disorders, obesity that is catching up, technological advancement, and an aging population.

The prevalence of sleep apnea exists for approximately 30 million Americans and is one of the popular solutions sought by patients as the NIH has rightly increased funding to $400 million for the study of sleep disorders. High costs, limited insurance coverage, and compliance of patients have restricted market growth. Acceptance of home sleep tests and telemedicine brings with it opportunities that promote the demand for non-invasive treatments, propelled by interest in health and wellness. Among such trends are those related to AI-powered smart devices, personalized appliances, minimally invasive surgeries, and public funds supporting the development of telemedicine and efforts in wellness.

Key Players

SomnoMed Ltd, Airway Management, Inc, Resmed Inc, Pure Sleep Company, Biotronik Se & Co. Kg, Meditas Ltd, Sleeping Well, LLC, Somnomed Limited, The Pure Sleep Company, Tomed Dr. Toussaint Gmbh, Apnea Sciences Corporation, Theravent, Inc., GlaxoSmithKline, PLC and among others

Key Takeaways

  • Expiratory Positive Airway Pressure, or EPAP devices, are growing fast. EPAP devices work by using airflow resistance to keep the airway open while patient’s exhale. It has gained popularity as a non-invasive alternative to Continuous Positive Airway Pressure, or CPAP machines, with portability and convenience that is attractive to new users.
  • Uvulopalatopharyngoplasty (UPPP) remains the most common surgical procedure. UPPP is a well-established surgical procedure for the treatment of chronic snoring and sleep apnea, usually performed in patients in whom conservative treatment has failed and are therefore seeking a safe alternative.
  • The prevalence has increased recently, and with estimates close to 20–30% in men and 10–15% in women in North America, obesity is the root cause of OSA.
  • A recent report by the American Academy of Sleep Medicine (AASM) states that OSA affects 12% of the US adult population, equivalent to 29.4 million individuals, and 80% of these are undiagnosed.

Key Developments

  • Oct 2024: Airway Management, has introduced a product most recently flexTAP-a new, top-of-the-line, in-lab-milled oral appliance designed to treat snorers and patients suffering from mild to moderate obstructive sleep apnea.
  • March 2024: ResMed, the global leader in digital health and cloud-connected medical devices, which transform care for people with sleep apnea and other chronic respiratory diseases, announced the U.S. launch of the AirFit F40, the ultra-compact, full-face mask that gives users the comfort of smaller masks without sacrificing performance to help improve sleep apnea therapy compliance.

US Anti-Snoring Devices and Snoring Surgery Market Segmentation

By Device: Mandibular Advancement Devices (MADs)are currently the most widely adopted, dominating segment due to their effectiveness in mild to moderate obstructive sleep apnea (OSA) cases. MADs are popular as they reposition the jaw to prevent airway obstruction, reducing snoring and improving sleep quality.

By Surgical Procedure: Uvulopalatopharyngoplasty (UPPP)remains the most performed surgical procedure. UPPPis an established treatment for chronic snoring and sleep apnea, usually done after failing other treatment interventions, so it becomes a reliable intervention.

By Distribution Channel: Hospitals lead in this segment due to their comprehensive range of treatment options and specialized facilities for complex cases, including surgeries and advanced diagnostics.

US Anti-Snoring Devices and Snoring Surgery Market Dynamics

Drivers

Some elements of the U.S. population start becoming more aware of sleep disorders, such as snoring and sleep apnea. The AASM reports that an estimated nearly 30 million Americans have obstructive sleep apnea, most undiagnosed. Public campaigns by the CDC want to expand public awareness of how poor-quality sleep is connected with chronic diseases; thus, demand for anti-snoring solutions is increased. Innovations are being funded by the government.

For instance, the NIH annually invests more than $400 million in studies related to sleep disorders, which continues to advance anti-snoring products. Obesity is a significant contributor to snoring. The CDC states that approximately 42% of U.S. adults are obese, a factor linked to increased snoring risk due to airway obstruction. This epidemic has driven demand for anti-snoring devices, as individuals seek solutions to mitigate snoring-related health risks. Public health programs addressing obesity indirectly boost demand for anti-snoring interventions.

Technology has resulted in high-tech anti-snoring appliances, including smart wearables and mobile-controlled appliances. These innovations enhance comfort and effectiveness as they help patients effectively manage snoring and sleep apnea. Such research funding that NIH and FDA have supported advanced anti-snoring devices results in effective treatment; therefore, treatments become accessible and appealing. The number of older adults in the U.S. is growing, and this is a resultant rise in sleep-related disorders, such as snoring. According to the U.S. Census Bureau, the geriatric population will be doubled by 2060, thus increasing the necessity for anti-snoring devices and treatments.

Constraints

Surgical anti-snoring treatments may be quite expensive, at anywhere between $3,000-$5,000. The lack of insurance coverage would significantly limit the growth of this market because many patients cannot afford the surgery due to financial constraints and usually prefer non-surgical remedies. Some anti-snoring surgeries and devices may also cause discomfort, dry mouth, or other side effects. So, most patients, being well aware of such side effects, may refrain from opting for surgical or device-based treatments. Many insurance plans classify anti-snoring treatments as elective, limiting coverage. Consequently, patients bear out-of-pocket costs, hindering market growth. Legislative efforts to extend coverage to sleep-related treatments have yet to make significant progress. Non-compliance, particularly with CPAP (Continuous Positive Airway Pressure) machines, limits effectiveness. Studies show that up to 50% of patients struggle with long-term CPAP use, impacting demand.

Opportunities

Home sleep tests offer an accessible, affordable way to diagnose snoring issues, increasing awareness and demand for treatment. The FDA’s recent approval of at-home testing kits makes diagnosis more accessible, and Medicare has expanded coverage for these tests, driving market growth. Non-invasive options like nasal strips and chin straps have gained popularity. Demand for alternatives to CPAP is rising, prompting innovation in new devices. Telemedicine enables remote diagnosis and consultation for sleep disorders, which reduces healthcare costs and improves patient access. Federal investments, such as the $200 million CARES Act telehealth funding, have accelerated telemedicine, boosting market potential. A growing interest in wellness supports proactive approaches to sleep health. U.S. wellness spending is estimated to grow 5-10% annually, and snoring treatment solutions are becoming part of preventive health.

Trends

Smart anti-snoring devices with AI guarantee personalized therapy adjustment and user experience. FDA-approved AI devices have grown 40% since 2020, a reflection of growing interest. Custom-fitted appliances increase comfort and compliance and patients love them. Dentists and sleep specialists increasingly work in concert with each other to develop tailored devices, thus enhancing effectiveness. In addition, the market is strengthened by partnerships between device manufacturers and healthcare providers. Mergers, like those recently finalized between ResMed, demonstrate growth and enhance sleep health focus. Minimally invasive surgical procedures, including laser-assisted ones, include a reduced recovery time and decreased complications and attract patients looking for alternatives to CPAP.

Us Anti Snoring Devices And Snoring Surgery Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2023

US$ 538.6 million

Market Size in 2030

US$ 917.1 million

By Device

  • Oral Devices Mandibular Advancement Devices (MADS)
  • Tongue-Retaining Devices (TRDS)
  • Nasal Dilator
  • Chin Strap
  • Position Control
  • Tongue Stabilizing Devices
  • Expiratory Positive Airway Pressure

By Surgical Procedure

  • Uvulopalatopharyngoplasty
  • Pillar Procedure
  • Laser-Assisted Uvulopalatoplasty
  • Radiofrequency Ablation
  • Sclerotherapy
  • Septoplasty
  • Palatal Stiffening Procedures
  • Injection Snoreplasty/Sclerotherapy

By Distribution Channel

  • Hospitals
  • Clinics

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Analyst Review

U.S. Anti-Snoring Devices and Snoring Surgery Market--one of the most promising, high-growth sectors that will be driven by increased awareness of sleep disorder conditions and by technological advancements. Increased rates of obesity are especially widespread among older age groups and stimulate demand for both device-based and surgical solutions. High cost, limited insurance coverage, and low compliance with CPAP remain major obstacles. Even as the market is shifting toward AI-integrated smart devices, telemedicine, and non-invasive solutions are part of an expanding wellness trend-strategic partnerships among providers with innovative technologies will accelerate the growth of the market even further, meeting demand in the coming years for more accessible and effective anti-snoring solutions.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The US anti-snoring devices and snoring surgery market size was valued at US$ 538.6 million in 2023 and is projected to reach US$ 917.1 million by 2030, growing at a CAGR of 7.9% from 2024 to 2030.

• AI-Driven and Smart Snoring Solutions
• Rising Demand for Customized Devices
• Partnerships and Mergers in the Market
• Growth in Minimally Invasive Surgical Procedures

• Growing Awareness of Sleep Disorders
• Rising Incidence of Obesity
• Technological Advancements
• Increasing Geriatric Population

• High Cost of Surgical Procedures
• Side Effects and Complications
• Lack of Insurance Coverage
• Patient Compliance

Uvulopalatopharyngoplasty surgical procedures have the highest share in the anti-snoring devices and snoring surgery market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. U.S. Anti-Snoring Devices and Snoring Surgery Market Introduction
2.1. U.S. Anti-Snoring Devices and Snoring Surgery Market Taxonomy
2.2. U.S. Anti-Snoring Devices and Snoring Surgery Market Definitions
2.2.1. Device
2.2.2. Surgical Procedure
2.2.3. Distribution Channel
3. U.S. Anti-Snoring Devices and Snoring Surgery Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. U.S. Anti-Snoring Devices and Snoring Surgery Market Dynamic Factors - Impact Analysis
3.6. U.S. Anti-Snoring Devices and Snoring Surgery Market Competition Landscape
4. U.S. Anti-Snoring Devices and Snoring Surgery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Device, 2019 - 2023 and Forecast, 2024 - 2030
5.1. Oral Devices
5.1.1. Mandibular Advancement Devices (MADS)
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Tongue-Retaining Devices (TRDS)
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Nasal Dilator
5.2.1. External Nasal Dilators (Nasal Strips)
5.2.2. Other Nasal Devices (Nasal Stents, Nasal Clips, and Septal Stimulators)
5.3. Chin Strap
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Position Control
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Tongue Stabilizing Devices
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Expiratory Positive Airway Pressure
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Surgical Procedure, 2019 - 2023 and Forecast, 2024 - 2030
6.1. Uvulopalatopharyngoplasty
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Pillar Procedure
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Laser-Assisted Uvulopalatoplasty
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Radiofrequency Ablation
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Sclerotherapy
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Septoplasty
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Palatal Stiffening Procedures
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Injection Snoreplasty/Sclerotherapy
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.9. U.S. Anti-Snoring Devices and Snoring Surgery Market - Opportunity Analysis Index, By Device, By Surgery, By Distribution Channel, and Region, 2024 - 2030
7. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. U.S. Anti-Snoring Devices and Snoring Surgery Market - Opportunity Analysis Index, By Device, By Surgery, By Distribution Channel, and Region, 2022 2028
9. Competition Landscape 
9.1. Strategic Dashboard of Top Market Players
9.2. Company Profiles (Introduction, Financial Analysis, Feedstock Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
9.2.1. Pure Sleep Company
9.2.2. Airway Management Inc.
9.2.3. Biotronik Se & Co. Kg
9.2.4. Recent Developments
9.2.5. Meditas Ltd
9.2.6. Sleeping Well, LLC
9.2.7. Somnomed Limited
9.2.8. The Pure Sleep Company
9.2.9. Tomed Dr. Toussaint Gmbh
9.2.10. Apnea Sciences Corporation
9.2.11. Theravent, Inc.
9.2.12. Glaxosmithkline, PLC
10. Research Methodology
11. Key Assumptions and Acronyms

Key Market Players

  • SomnoMed Ltd
  • Airway Management
  • Resmed Inc
  • Pure Sleep Company
  • Biotronik Se & Co. Kg
  • Meditas Ltd
  • Sleeping Well
  • Somnomed Limite
  • The Pure Sleep Company
  • Apnea Sciences Corporation
  • Theravent
  • GlaxoSmithKline

Related Industry Reports